Delray Beach, Florida
United States
37
2026-04-09
The entities that hold a legal rights for patent applications filed by inventor Rothbaum Wayne:
Wayne Rothbaum from Delray Beach, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Methods of Treating Myeloproliferative Neoplasms
#2 | 2026-02-12METHODS OF TREATING INDOLENT SYSTEMIC MASTOCYTOSIS
#3 | 2025-12-25METHODS OF TREATING MYELOPROLIFERATIVE NEOPLASMS
#4 | 2025-11-27METHODS OF TREATING INDOLENT SYSTEMIC MASTOCYTOSIS
#5 | 2025-09-16Methods of treating indolent systemic mastocytosis
#6 | 2025-05-01METHODS OF TREATING CANCER DEPENDENT ON MYC GENE EXPRESSSION
#7 | 2025-05-01METHODS OF TREATING A CANCER OVEREXPRESSING ONE OR MORE BCL-2 FAMILY PROTEINS
#8 | 2025-03-20Methods of Treating Cancer
#9 | 2024-07-04BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
#10 | 2024-06-20Therapeutic Combinations of a CD19 Inhibitor and a BTK Inhibitor
#11 | 2022-12-08COMBINATION OF A BTK INHIBITOR AND AN MDM2 INHIBITOR FOR CANCER TREATMENT
#12 | 2022-03-24Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor
#13 | 2022-02-24Methods of treating myeloproliferative neoplasms
#14 | 2022-02-10Methods and Compositions of Treating an Ophthalmic Condition
#15 | 2021-11-11BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
#16 | 2021-06-24Methods of treating cancer
#17 | 2020-03-05Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, a PD-1 Inhibitor, and/or a PD-L1 Inhibitor
#18 | 2020-03-05Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor
#19 | 2019-12-19BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
#20 | 2019-12-12Therapeutic Combinations of an Antifolate and a BTK Inhibitor
#21 | 2019-12-12Therapeutic combinations of a MEK inhibitor and a BTK inhibitor
#22 | 2019-07-11Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor
#23 | 2019-01-24Therapeutic Combinations of a BTK Inhibitor and a GITR Binding Molecule, a 4-1BB Agonist, or an OX40 Agonist
#24 | 2019-01-10Therapeutic Combinations of an Antifolate and a BTK Inhibitor
#25 | 2019-01-10Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor
#26 | 2018-12-27BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
#27 | 2018-11-08Therapeutic Combinations of a CD19 Inhibitor and a BTK Inhibitor
#28 | 2018-09-06Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a CDK4/6 Inhibitor
#29 | 2018-09-06Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor
#30 | 2018-07-26Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor and/or a JAK-2 Inhibitor
#31 | 2017-08-24Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, a PD-1 Inhibitor, and/or a PD-L1 Inhibitor
#32 | 2017-08-17BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
#33 | 2017-08-17Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a BCL-2 Inhibitor
#34 | 2017-08-10Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a CDK 4/6 Inhibitor
#35 | 2017-05-18Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/or a JAK-2 inhibitor
#36 | 2017-03-16Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor
#37 | 2017-02-09Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor
1790500 ⎘